Dengue is a mosquito-borne infectious disease
affecting humans and animals caused by dengue virus belonging to the
Flaviviridae family and genus Flavivirus. Dengue is typically transmitted from
human to human through the bite of an infected aedes aegypti mosquito. Symptoms
of dengue include high fever, headache, fatigue, muscle pain, diarrhea, anemia,
skin rashes and vomiting. Severe dengue can cause yellow skin, seizures, coma,
or death. Dengue has high mortality rate and can cause various complications in
the neurology. Dengue causes CNS manifestations which includes any degree of
impaired consciousness, abnormal neurological signs, delirium, and focal and
generalized convulsions. Causes of neurological manifestations in dengue are
due to high-grade fever. A number of tests are available to confirm the
diagnosis including detecting antibodies to the virus or it’s RNA. Management
of dengue is a challenge that is needed to be addressed. There are different
causes underlying the clinical event of dengue for which multimodal and
effective treatment approach is required. Among the effective treatments,
vaccines are considered to be the best available precaution option for dengue.
Several vaccines currently under clinical trial have shown promising effects,
includes TVD, TV003, TV005, TVDV and TDENV. Expected approval for the vaccine
TV003 (by Butantan Institute.) a live attenuated vaccine in the next few years
is likely to drive the market
Read Report
Overview: https://www.transparencymarketresearch.com/dengue-vaccine-market.html
The global dengue vaccine market has been segmented
based on product, distribution channel, and region. In terms of product, the
market has been categorized into only one product i.e. CYD-TDV (Dengvaxia)
because only one vaccine of Sanofi Pasteur is approved in the market. The
product segment tend to show lucrative growth in the dengue vaccine market due
to increasing incidence of dengue globally and effective way to avoid the virus
causing dengue. Based on distribution channel, the market has been classified
into hospital pharmacies, retail pharmacies, drug store, online pharmacies, and
others. The hospitals pharmacies segment held the largest share of the market
due to easy access for outpatient department (OPD) patients to buy medicines.
Online pharmacies are likely to witness lucrative growth during the forecast
period due to increasing online purchase by patients and various discounts
offered by online stores.
Request a
Sample of Dengue Vaccine Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28397
Geographically, the dengue vaccine market has been
segmented into five major regions: North America (U.S. and Canada), Europe
(Germany, France, U.K., etc.), Asia Pacific (Australia, China, Japan, India,
etc.), Latin America (Brazil, Mexico, etc.), and Middle East &Africa (GCC
Countries, South Africa, etc.). North America is the leading market for dengue
vaccine in terms of revenue, followed by Europe. The U.S. holds the largest
share of the market in the region. Asia Pacific and Latin America are emerging
markets, which are expected to witness strong growth during the forecast period
from 2017 to 2025. Strong growth in these regions is attributed to increasing
incidence of dengue, rising health care industries, and increase in government investment
to develop health care infrastructure. The dengue vaccine market in countries
such as China, India, and Brazil is projected to expand at high growth rate
during the forecast period due to increase in awareness among the population
about dengue disease and its treatment.
Enquiry
Before Buying Dengue Vaccine Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=28397
Other factors that drive the dengue vaccine market
are rising prevalence of dengue, increasing novel drug treatment, convenience
of direct purchase, affordability of vaccine, high adoption and acceptance in
developing markets, and innovations and developments in vaccine. The market is
also experiencing certain restraints such as stiff competition among existing
players to develop new vaccine, high possibilities of side effect of vaccine,
complications and severity involved in taking wrong medications due to
misdiagnosis or incorrect self-diagnosis, and lack of awareness among the rural
population in developing and underdeveloped economies.
Pre-Book
Dengue Vaccine Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=28397<ype=S
Major players operating in the dengue vaccine market
include Sanofi Pasteur, Panacea Biotec, Biological E. Limited, GlaxoSmithKline
plc, Merck & Co., Inc. and Takeda Pharmaceutical Company Ltd.
More Trending
Reports by Transparency Market Research:
https://www.prnewswire.co.uk/news-releases/carbon-therapy-segment-in-particle-therapy-market-to-grow-at-exponential-growth-rate-from-2018-to-2026-tmr-848789727.html
https://www.prnewswire.com/news-releases/strides-in-positive-airway-pressure-devices-market-help-reduce-worldwide-prevalence-of-obstructive-sleep-apnea-valuation-to-rise-at-cagr-of-7-8-from-2019-to-2027-tmr-301136571.html
About Us
Transparency Market Research is a next-generation market
intelligence provider, offering fact-based solutions to business leaders,
consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along with ability to
track more than one million high growth niche products are aligned with your
aims. The detailed and proprietary statistical models used by our analysts offer
insights for making right decision in the shortest span of time. For
organizations that require specific but comprehensive information we offer
customized solutions through ad hoc reports. These requests are delivered with
the perfect combination of right sense of fact-oriented problem solving
methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific
problems with right methodology of research is the key to help enterprises
reach right decision.
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
